Login / Signup

Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study.

Gilad KaravaniHenry H ChillNatali Schachter-SafraiGan LomnitzDavid GillisDvora Bauman
Published in: Clinical diabetes and endocrinology (2021)
GnRHa treatment for precocious puberty is not associated with increased risk of polycystic ovary syndrome.
Keyphrases
  • polycystic ovary syndrome
  • insulin resistance
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • replacement therapy